{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:08:15Z","timestamp":1780988895716,"version":"3.54.1"},"reference-count":114,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EORTC Quality of Life Group","award":["010\/2022"],"award-info":[{"award-number":["010\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient-reported outcome (PRO) item libraries support flexible PRO assessment in cancer research by facilitating the development of customized item lists. However, little is known about the use of item lists in clinical research. This systematic review addresses this by assessing utilization of PRO item libraries and lists in oncology research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of MEDLINE, Embase, and CINAHL identified cancer studies using PRO item libraries to develop item lists, regardless of study design, published between October 2021 and September 2025. Key features of item library usage were extracted and analyzed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 78 studies were included (25 trials and feasibility, 53 observational). The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events system was frequently used (49 of 78), and symptom assessment was the most common application (63 of 78). Item lists were implemented across different settings including novel treatments (19 of 78) and rare cancers (15 of 78). Most item lists were derived from a single PRO item library (72 of 78). In some studies, there was additional customization such as item wording changes (5 of 78) or addition of items adapted from the item library (9 of 78). Item selection methods included literature (32 of 78), patient involvement (8 of 78) and consultation with health-care professionals (11 of 78). Many studies (40 of 78) did not report methods used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PRO item libraries are increasingly used to create customized item lists in oncology research, primarily for symptom assessment. However, reporting practices for methods used are inconsistent, highlighting the need for standardized guidelines for reporting PRO item lists in clinical trials and routine care to improve transparency, reproducibility, and quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag039","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:33:54Z","timestamp":1770640434000},"page":"971-996","source":"Crossref","is-referenced-by-count":0,"title":["Systematic review of patient-reported outcome item libraries in cancer research: an EORTC Quality of Life Group study"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-5339","authenticated-orcid":false,"given":"Rosemary","family":"Peacock","sequence":"first","affiliation":[{"name":"Leeds Institute for Medical Research, University of Leeds, St James\u2019s Hospital , Leeds,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9577-1463","authenticated-orcid":false,"given":"Christopher","family":"Bedding","sequence":"additional","affiliation":[{"name":"Leeds Institute for Medical Research, University of Leeds, St James\u2019s Hospital , Leeds,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0596-7682","authenticated-orcid":false,"given":"Bonnie","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-2599","authenticated-orcid":false,"given":"Hayat","family":"Hamzeh","sequence":"additional","affiliation":[{"name":"Leeds Institute for Medical Research, University of Leeds, St James\u2019s Hospital , Leeds,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-1174","authenticated-orcid":false,"given":"Claire","family":"Piccinin","sequence":"additional","affiliation":[{"name":"Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-1227","authenticated-orcid":false,"given":"Alexandra","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Leeds Institute for Medical Research, University of Leeds, St James\u2019s Hospital , Leeds,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026060902511378500_djag039-B1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1200\/edbk_200383","article-title":"Implementation of patient-reported outcomes in routine medical care","volume":"38","author":"Basch","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026060902511378500_djag039-B2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"key":"2026060902511378500_djag039-B3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jval.2020.11.004","article-title":"Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review","volume":"24","author":"Giesinger","year":"2021","journal-title":"Value Health"},{"key":"2026060902511378500_djag039-B4","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s11136-024-03767-0","article-title":"Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients","volume":"33","author":"Geurts","year":"2024","journal-title":"Qual Life Res"},{"key":"2026060902511378500_djag039-B5","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.eclinm.2024.102838","article-title":"Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials \u2013 insights from an expert virtual roundtable","volume":"76","author":"Yap","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2026060902511378500_djag039-B6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2019.08.016","article-title":"Current state of quality of life and patient-reported outcomes research","volume":"121","author":"Bottomley","year":"2019","journal-title":"Eur J Cancer"},{"key":"2026060902511378500_djag039-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"2026060902511378500_djag039-B8","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.ejca.2010.08.002","article-title":"Choosing patient-reported outcome measures for cancer clinical research \u2013 Practical principles and an algorithm to assist non-specialist researchers","volume":"46","author":"Luckett","year":"2010","journal-title":"Eur J Cancer"},{"key":"2026060902511378500_djag039-B9","author":"Wheelwright","year":"2021"},{"key":"2026060902511378500_djag039-B10","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1016\/s1470-2045(22)00654-4","article-title":"Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group","volume":"24","author":"Piccinin","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026060902511378500_djag039-B11","author":"U.S. Food & Drug Administration","year":"2024"},{"key":"2026060902511378500_djag039-B12","author":"European Organisation for Research and Treatment of Cancer Quality of Life","year":"2023"},{"key":"2026060902511378500_djag039-B13","author":"FACIT.org","year":"2025"},{"key":"2026060902511378500_djag039-B14","author":"MD Anderson Cancer Center","year":"2025"},{"key":"2026060902511378500_djag039-B15","author":"National Cancer Institute","year":"2025"},{"key":"2026060902511378500_djag039-B16","author":"National Cancer Institute","year":"2025"},{"key":"2026060902511378500_djag039-B17","author":"National Cancer Institute","year":"2025"},{"key":"2026060902511378500_djag039-B18","author":"Health Measures","year":"2025"},{"key":"2026060902511378500_djag039-B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41591-021-01648-4","article-title":"The value of patient-reported outcomes in early-phase clinical trials","volume":"28","author":"Retzer","year":"2022","journal-title":"Nat Med"},{"key":"2026060902511378500_djag039-B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"2026060902511378500_djag039-B21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/jnci\/djac128","article-title":"Listening to the patient voice adds value to cancer clinical trials","volume":"114","author":"Brundage","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2026060902511378500_djag039-B22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1200\/JCO.20.02015","article-title":"Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy","volume":"39","author":"Absolom","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026060902511378500_djag039-B23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann Oncol"},{"key":"2026060902511378500_djag039-B24","author":"Crossnohere","year":"2023"},{"key":"2026060902511378500_djag039-B25","author":"U.S. Food & Drug Administration","year":"2009"},{"key":"2026060902511378500_djag039-B26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s1470-2045(25)00150-0","article-title":"Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop","volume":"26","author":"Pe","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026060902511378500_djag039-B27","year":"2024"},{"key":"2026060902511378500_djag039-B28","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026060902511378500_djag039-B29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"Educ Inform"},{"key":"2026060902511378500_djag039-B30","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.11124\/jbisrir-d-19-00169","article-title":"Methodological guidance for the conduct of mixed methods systematic reviews","volume":"18","author":"Stern","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2026060902511378500_djag039-B31","author":"PROSPERO"},{"key":"2026060902511378500_djag039-B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jncics\/pkaf032","article-title":"Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial","volume":"9","author":"Bandos","year":"2025","journal-title":"JNCI Cancer Spectrum"},{"key":"2026060902511378500_djag039-B33","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1200\/JCO.23.00903","article-title":"Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)","volume":"41","author":"Basch","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026060902511378500_djag039-B34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ygyno.2025.02.023","article-title":"Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)","volume":"195","author":"Carter","year":"2025","journal-title":"Gynecol Oncol"},{"key":"2026060902511378500_djag039-B35","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1089\/jpm.2021.0187","article-title":"Improving palliative care and quality of life in pancreatic cancer patients","volume":"25","author":"Chung","year":"2022","journal-title":"J Palliat Med"},{"key":"2026060902511378500_djag039-B36","doi-asserted-by":"publisher","first-page":"e35599","DOI":"10.1002\/cncr.35599","article-title":"Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer","volume":"131","author":"Compton","year":"2025","journal-title":"Cancer"},{"key":"2026060902511378500_djag039-B37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1200\/jco.22.00738","article-title":"Effects of a geriatric assessment intervention on patient-reported symptomatic toxicity in older adults with advanced cancer","volume":"41","author":"Culakova","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026060902511378500_djag039-B38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.36401\/JIPO-23-9","article-title":"Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer","volume":"6","author":"de Almeida","year":"2023","journal-title":"J Immunother Prec Oncol"},{"key":"2026060902511378500_djag039-B39","doi-asserted-by":"publisher","first-page":"e50550","DOI":"10.2196\/50550","article-title":"Supportive digital health service during cancer chemotherapy: single-arm before-and-after feasibility study","volume":"7","author":"Fridriksdottir","year":"2023","journal-title":"JMIR Form Res."},{"key":"2026060902511378500_djag039-B40","doi-asserted-by":"publisher","first-page":"e46128","DOI":"10.2196\/46128","article-title":"Feasibility of a text messaging-integrated and chatbot-interfaced self-management program for symptom control in patients with gastrointestinal cancer undergoing chemotherapy: pilot mixed methods study","volume":"7","author":"Gomaa","year":"2023","journal-title":"JMIR Form Res."},{"key":"2026060902511378500_djag039-B41","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s12325-025-03136-4","article-title":"Patient-reported outcomes for patients with previously treated small cell lung cancer receiving Tarlatamab: results from the DeLLphi-301 phase 2 trial","volume":"42","author":"Hummel","year":"2025","journal-title":"Adv Ther"},{"key":"2026060902511378500_djag039-B42","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1016\/S2352-3026(25)00163-2","article-title":"Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial","volume":"12","author":"Hungria","year":"2025","journal-title":"Lancet Haematol"},{"key":"2026060902511378500_djag039-B43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4040\/jkan.25011","article-title":"Effectiveness of a mobile application for tracking symptoms and enhancing symptom management among breast cancer patients receiving chemotherapy in Bangkok, Thailand: a non-randomized controlled trial","volume":"55","author":"Kaveenuntachai","year":"2025","journal-title":"J Korean Acad Nurs"},{"key":"2026060902511378500_djag039-B44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.pmn.2021.11.010","article-title":"Self-reported severity, characteristics, and functional limitations of chemotherapy-induced peripheral neuropathy","volume":"23","author":"Knoerl","year":"2022","journal-title":"Pain Manag Nurs"},{"key":"2026060902511378500_djag039-B45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00520-024-09062-5","article-title":"Feasibility and usefulness of symptom monitoring with electronic patient-reported outcomes: an experience at single-center outpatient oncology clinic","volume":"33","author":"Kurosawa","year":"2024","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/JS9.0000000000001845","article-title":"Efficacy of a smartphone application assisting home-based rehabilitation and symptom management for patients with lung cancer undergoing video-assisted thoracoscopic lobectomy: a prospective, single-blinded, randomised control trial (POPPER study)","volume":"111","author":"Lv","year":"2025","journal-title":"Int J Surg"},{"key":"2026060902511378500_djag039-B47","doi-asserted-by":"publisher","first-page":"101073","DOI":"10.1016\/j.adro.2022.101073","article-title":"Web-based symptom monitoring with patient-reported outcomes during definitive radiation therapy with chemotherapy (SYMPATHY): a prospective single-center phase 1 study","volume":"8","author":"Ma","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"2026060902511378500_djag039-B48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygyno.2022.08.006","article-title":"Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian ca","volume":"167","author":"Madariaga","year":"2022","journal-title":"Gynecol Oncol"},{"key":"2026060902511378500_djag039-B49","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2352-3026(22)00284-8","article-title":"Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study","volume":"9","author":"Martin","year":"2022","journal-title":"Lancet Haematol"},{"key":"2026060902511378500_djag039-B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/COC.0000000000001007","article-title":"Feasibility trial of intensity modulated proton therapy to reduce toxicity in anal cancer patients","volume":"46","author":"Nelson","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"2026060902511378500_djag039-B51","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1007\/s00520-022-07312-y","article-title":"Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy","volume":"30","author":"Nielsen","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijrobp.2025.01.005","article-title":"Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT)","volume":"122","author":"Ohri","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026060902511378500_djag039-B53","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(24)00373-5","article-title":"Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"25","author":"Oliveira","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026060902511378500_djag039-B54","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/oncolo\/oyae088","article-title":"Health-related quality of life with sacituzumab govitecan in HR+\/HER2\u2212 metastatic breast cancer in the phase III TROPiCS-02 trial","volume":"29","author":"Rugo","year":"2024","journal-title":"Oncologist"},{"key":"2026060902511378500_djag039-B55","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1470-2045(25)00233-5","article-title":"Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial","volume":"26","author":"Saito","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026060902511378500_djag039-B56","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/JCO.21.02831","article-title":"Intensity-modulated radiation therapy reduces patient-reported chronic toxicity compared with conventional pelvic radiation therapy: updated results of a phase III trial","volume":"40","author":"Yeung","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026060902511378500_djag039-B57","doi-asserted-by":"publisher","first-page":"17740","DOI":"10.1002\/cam4.6394","article-title":"Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment","volume":"12","author":"Adesoye","year":"2023","journal-title":"Cancer Med"},{"key":"2026060902511378500_djag039-B58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5505\/tjo.2025.4434","article-title":"The impact of prebiotic, fiber and glutamine supplementation on bowel symptoms and quality of life in prostate cancer patients undergoing pelvic radiotherapy","volume":"40","author":"Akmansu","year":"2025","journal-title":"TJ Oncol"},{"key":"2026060902511378500_djag039-B59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14338\/IJPT-22-00020.1","article-title":"Outcomes of proton beam therapy compared with intensity-modulated radiation therapy for uterine cancer","volume":"9","author":"Anderson","year":"2023","journal-title":"Int J Part Ther"},{"key":"2026060902511378500_djag039-B60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/BCTT.S412338","article-title":"PRO Hair Safe Study: the patient\u2019s perspective on the effects of scalp cooling on hair preservation","volume":"15","author":"Brunner","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2026060902511378500_djag039-B61","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-023-14618-6","article-title":"Biopsychosocial late effects after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases from colorectal and appendiceal cancer: a national prospective cohort study","volume":"31","author":"Balachandran","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026060902511378500_djag039-B62","doi-asserted-by":"publisher","first-page":"306.e1","DOI":"10.1016\/j.ajog.2024.09.001","article-title":"Patient-reported lymphedema after sentinel lymph node mapping in women with low-grade endometrial cancer","volume":"232","author":"Bjornholt","year":"2025","journal-title":"Am J Obst Gynecol"},{"key":"2026060902511378500_djag039-B63","doi-asserted-by":"publisher","first-page":"03","DOI":"10.1093\/dote\/doaf067","article-title":"Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection-use of a novel symptom response questionnaire","volume":"38","author":"Chevallay","year":"2025","journal-title":"Dis Esophagus"},{"key":"2026060902511378500_djag039-B64","doi-asserted-by":"publisher","first-page":"e091769","DOI":"10.1136\/bmjopen-2024-091769","article-title":"Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD)","volume":"15","author":"Conti","year":"2025","journal-title":"BMJ Open"},{"key":"2026060902511378500_djag039-B65","doi-asserted-by":"publisher","first-page":"20:134-149","DOI":"10.1007\/s11764-024-01641-z","article-title":"Prevalence and determinants of sleep problems in cancer survivors compared to a normative population: a PROFILES registry study","author":"David","year":"2024","journal-title":"J Cancer Survivorship"},{"key":"2026060902511378500_djag039-B66","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1007\/s00520-022-06929-3","article-title":"Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data","volume":"30","author":"den Hollander","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B67","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/hsc.13467","article-title":"The added value of palliative day care centres: a full-population cross-sectional survey among clients and their family caregivers in Flanders, Belgium","volume":"30","author":"Dierickx","year":"2022","journal-title":"Health Soc Care Community"},{"key":"2026060902511378500_djag039-B68","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1177\/10499091231223964","article-title":"The association between an electronic health record (EHR)\u2013embedded frailty index and patient-reported outcomes among patients with metastatic non\u2013small-cell lung cancer on immunotherapy: a brief report","volume":"41","author":"Gabbard","year":"2024","journal-title":"Am J Hosp Palliat Med"},{"key":"2026060902511378500_djag039-B69","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/NCC.0000000000001223","article-title":"Subjective toxicity profiles of children with cancer during treatment: a latent class analysis","volume":"47","author":"Ruan","year":"2024","journal-title":"Cancer Nurs"},{"key":"2026060902511378500_djag039-B70","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00520-025-09653-w","article-title":"Symptom burden and symptom clusters in patients with breast cancer undergoing endocrine therapy: a cross-sectional survey","volume":"33","author":"Han","year":"2025","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B71","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.21873\/anticanres.16056","article-title":"Surgery, limb edema and health-related quality of life: a prospective follow-up study on patients with cutaneous malignant melanoma","volume":"42","author":"Heino","year":"2022","journal-title":"Anticancer Res"},{"key":"2026060902511378500_djag039-B72","doi-asserted-by":"publisher","first-page":"e2410145","DOI":"10.1001\/jamanetworkopen.2024.10145","article-title":"Multilevel characteristics of cumulative symptom burden in young survivors of childhood cancer","volume":"7","author":"Horan","year":"2024","journal-title":"JAMA Network Open"},{"key":"2026060902511378500_djag039-B73","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1007\/s00520-022-07347-1","article-title":"Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors","volume":"30","author":"Hsu","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B74","doi-asserted-by":"publisher","first-page":"151574","DOI":"10.1016\/j.soncn.2023.151574","article-title":"The symptom experience of patients with advanced melanoma undergoing immune checkpoint inhibitor (ICI) therapy","volume":"40","author":"Jackson-Carroll","year":"2024","journal-title":"Semin Oncol Nurs"},{"key":"2026060902511378500_djag039-B75","doi-asserted-by":"publisher","first-page":"e29986","DOI":"10.1002\/pbc.29986","article-title":"Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events","volume":"69","author":"Jacobs","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2026060902511378500_djag039-B76","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.jbo.2022.100420","article-title":"Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: final results of the PROBone registry study","volume":"33","author":"Jakob","year":"2022","journal-title":"J Bone Oncol"},{"key":"2026060902511378500_djag039-B77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5388\/aon.2023.23.2.84","article-title":"K. Skin-related quality of life in patients with lung cancer taking oral targeted agents: a single-center, cross-sectional study","volume":"23","author":"Joo Mi","year":"2023","journal-title":"Asian Oncol Nurs"},{"key":"2026060902511378500_djag039-B78","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.31557\/APJCP.2024.25.7.2475","article-title":"Changes in psychological condition during cancer chemotherapy","volume":"25","author":"Kamimura","year":"2024","journal-title":"Asian Pacific J Cancer Prev"},{"key":"2026060902511378500_djag039-B79","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijrobp.2022.05.041","article-title":"A comparison of patient- and clinician-reported acute toxic effects during radiation therapy for primary breast cancer","volume":"114","author":"Lapen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026060902511378500_djag039-B80","doi-asserted-by":"publisher","first-page":"e70204","DOI":"10.1002\/pon.70204","article-title":"Depressive and anxiety symptoms during chemotherapy for breast cancer and the potential impact of pre-treatment health behaviors","volume":"34","author":"Lau","year":"2025","journal-title":"Psycho-Oncol"},{"key":"2026060902511378500_djag039-B81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00520-023-07672-z","article-title":"Trajectories of participation in daily life among individuals newly diagnosed with cancer: a 5-month longitudinal study","volume":"31","author":"L\u2019Hotta","year":"2023","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B82","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1245\/s10434-024-15722-x","article-title":"Patient-reported outcomes in chinese patients with locally advanced or recurrent colorectal cancer after pelvic exenteration","volume":"31","author":"Lin","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026060902511378500_djag039-B83","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1016\/j.ijrobp.2025.08.053","article-title":"Prospective evaluation of patient priorities in HPV-driven oropharyngeal cancer using the chicago priorities scale: considerations for future clinical trial design","volume":"04","author":"McDowell","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026060902511378500_djag039-B84","doi-asserted-by":"publisher","first-page":"100802","DOI":"10.1016\/j.jtocrr.2025.100802","article-title":"Health utility and symptom scores in patients with advanced malignant pleural mesothelioma treated in a real-world setting","volume":"6","author":"Mittal","year":"2025","journal-title":"JTO Clin Res Rep"},{"key":"2026060902511378500_djag039-B85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jso.27871","article-title":"Financial toxicity of long-term survivors who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma","volume":"131","author":"Muaddi","year":"2025","journal-title":"Journal of Surgical Oncology"},{"key":"2026060902511378500_djag039-B86","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/ajo.13816","article-title":"Outpatient hysteroscopy: suitable for all? A retrospective cohort study of safety, success and acceptability in Australia","volume":"64","author":"Nash","year":"2024","journal-title":"Austr N Z J Obst Gynaecol"},{"key":"2026060902511378500_djag039-B87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s41687-022-00478-3","article-title":"An implementation study of electronic assessment of patient-reported outcomes in inpatient radiation oncology","volume":"6","author":"Nordhausen","year":"2022","journal-title":"J Patient Rep Outcomes"},{"key":"2026060902511378500_djag039-B88","doi-asserted-by":"publisher","first-page":"101574","DOI":"10.1016\/j.adro.2024.101574","article-title":"Stereotactic magnetic resonance-guided daily adaptive radiation therapy for localized prostate cancer: acute and late patient-reported toxicity outcomes","volume":"9","author":"Nugent","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"2026060902511378500_djag039-B89","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s11136-025-03891-5","article-title":"Comparison of patient-reported symptoms with multi-item patient-reported outcome measures of fatigue, anxiety, and depression in the clinical care of women undergoing chemotherapy for early breast cancer","volume":"34","author":"Nyrop","year":"2025","journal-title":"Qual Life Res"},{"key":"2026060902511378500_djag039-B90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s41687-024-00766-0","article-title":"Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study","volume":"8","author":"O\u2019Leary","year":"2024","journal-title":"J Patientreport Outcomes"},{"key":"2026060902511378500_djag039-B91","doi-asserted-by":"publisher","first-page":"465.e1","DOI":"10.1016\/j.jtct.2023.03.030","article-title":"A pilot trial of patient-reported outcomes for acute Graft-versus-Host-Disease","volume":"29","author":"Patel","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"2026060902511378500_djag039-B92","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00520-024-08985-3","article-title":"Symptom experience of patients undergoing treatment for multiple myeloma: a longitudinal real-world electronic patient-reported outcomes study","volume":"32","author":"Patel","year":"2024","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B93","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/smi.3193","article-title":"Psychological and somatic symptoms among breast cancer patients in four European countries: a cross-lagged panel model","volume":"39","author":"Roziner","year":"2023","journal-title":"Stress Health"},{"key":"2026060902511378500_djag039-B94","doi-asserted-by":"publisher","first-page":"303","DOI":"10.6004\/jadpro.2024.15.5.2","article-title":"Improving practice in a head and neck oncology clinic using the PRO-CTCAE tool","volume":"15","author":"Ruddy","year":"2024","journal-title":"J Adv Pract Oncol"},{"key":"2026060902511378500_djag039-B95","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.21037\/jgo-23-517","article-title":"Prospective observational study of zinc deficiency symptoms during first-line chemotherapy for gastric and colorectal cancer","volume":"14","author":"Sakaguchi","year":"2023","journal-title":"J Gastroint Oncol"},{"key":"2026060902511378500_djag039-B96","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijrobp.2024.09.041","article-title":"Real-world implementation of simulation-free radiation therapy (SFRT-1000): a propensity score-matched analysis of 1000 consecutive palliative courses delivered in routine care","volume":"121","author":"Schuler","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026060902511378500_djag039-B97","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s00277-023-05482-1","article-title":"Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system","volume":"102","author":"Shawahna","year":"2023","journal-title":"Ann Hematol"},{"key":"2026060902511378500_djag039-B98","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00520-024-08385-7","article-title":"Acute cancer-related symptoms and concerns among patients receiving chemotherapy: current state of the science","volume":"32","author":"Smith","year":"2024","journal-title":"Support Care Cancer"},{"key":"2026060902511378500_djag039-B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41687-021-00408-9","article-title":"Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry","volume":"6","author":"Thorpe","year":"2022","journal-title":"J Patient Rep Outcomes"},{"key":"2026060902511378500_djag039-B100","doi-asserted-by":"publisher","first-page":"e58611","DOI":"10.7759\/cureus.58611","article-title":"Barriers and facilitators to the implementation of an electronic patient-reported outcome system at cancer hospitals in Japan","volume":"16","author":"Uneno","year":"2024","journal-title":"Cureus"},{"key":"2026060902511378500_djag039-B101","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tipsro.2022.02.004","article-title":"Neurocognitive functioning following lung cancer treatment: the PRO-Long Study","volume":"21","author":"van der Weijst","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2026060902511378500_djag039-B102","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00520-024-08451-0","article-title":"Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study","volume":"32","author":"van de Wal","year":"2024","journal-title":"Support Care in Cancer"},{"key":"2026060902511378500_djag039-B103","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.cpnec.2021.100099","article-title":"Associations of meaning of illness with psychosocial, clinical, and immunological characteristics in patients with leptomeningeal metastasis","volume":"8","author":"Walker","year":"2021","journal-title":"Compr Psychoneuroendocrinol"},{"key":"2026060902511378500_djag039-B104","doi-asserted-by":"publisher","first-page":"930.e1","DOI":"10.1016\/j.jtct.2021.07.007","article-title":"Patient-reported symptom and functioning status during the first 12 months after chimeric antigen receptor T cell therapy for hematologic malignancies","volume":"27","author":"Wang","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2026060902511378500_djag039-B105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/NCC.0000000000001019","article-title":"Identification of breast cancer survivors with high symptom burden","volume":"45","author":"Whisenant","year":"2022","journal-title":"Cancer Nurs"},{"key":"2026060902511378500_djag039-B106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/NCC.0000000000001062","article-title":"Can steps per day reflect symptoms in children and adolescents undergoing cancer treatment?","volume":"45","author":"Withycombe","year":"2022","journal-title":"Cancer Nurs"},{"key":"2026060902511378500_djag039-B107","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jval.2022.01.023","article-title":"Electronic patient symptom management program to support patients receiving cancer treatment at home during the COVID-19 Pandemic","volume":"25","author":"Wujcik","year":"2022","journal-title":"Value Health"},{"key":"2026060902511378500_djag039-B108","doi-asserted-by":"publisher","first-page":"102451","DOI":"10.1016\/j.ejon.2023.102451","article-title":"Revealing symptom profiles: a pre-post analysis of docetaxel therapy in individuals with breast cancer","volume":"68","author":"Ya-Jung","year":"2024","journal-title":"European J Oncol Nurs"},{"key":"2026060902511378500_djag039-B109","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3816\/cgc.2005.n.017","article-title":"A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development","volume":"4","author":"Befort","year":"2005","journal-title":"Clin Prostate Cancer"},{"key":"2026060902511378500_djag039-B110","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/s0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"2026060902511378500_djag039-B111","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41591-024-02827-9","article-title":"Recommendations to address respondent burden associated with patient-reported outcome assessment","volume":"30","author":"Aiyegbusi","year":"2024","journal-title":"Nat Med"},{"key":"2026060902511378500_djag039-B112","author":"European Medicines Agency Committee for Medicinal Products for Human Use","year":"2016"},{"key":"2026060902511378500_djag039-B113","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1740774518799985","article-title":"Patient-reported outcomes version of the common terminology criteria for adverse events: methods for item selection in industry-sponsored oncology clinical trials","volume":"15","author":"Trask","year":"2018","journal-title":"Clin Trials"},{"key":"2026060902511378500_djag039-B114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12955-024-02244-z","article-title":"Acceptability and usefulness of the EORTC \u2018Write In three Symptoms\/Problems\u2019 (WISP): a brief open-ended instrument for symptom assessment in cancer patients","volume":"22","author":"Rojas-Concha","year":"2024","journal-title":"Health Qual Life Outcomes"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag039\/66938204\/djag039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/6\/971\/66938204\/djag039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/6\/971\/66938204\/djag039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:51:19Z","timestamp":1780987879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/6\/971\/8487771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":114,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag039","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,2,16]]}}}